{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/informed-consent-process-and-documentation”
},
“@id”: “https://www.clinicalstudies.in/informed-consent-process-and-documentation”,
“headline”: “SOP for Informed Consent Process and Documentation”,
“name”: “SOP for Informed Consent Process and Documentation”,
“description”: “Detailed SOP describing sponsor, investigator, and CRO responsibilities for the informed consent process and documentation in clinical trials in New Zealand, ensuring compliance with HDEC, Medsafe, and GCP.”,
“keywords”: “Informed consent SOP NZ, SOP for eConsent New Zealand, SOP for ICF compliance NZ, SOP for participant information NZ, SOP for cultural safety in consent NZ, SOP for consent documentation NZ, SOP for witness requirements NZ, SOP for illiterate subject consent NZ, SOP for vulnerable populations consent NZ, SOP for consent form version control NZ, SOP for PI responsibilities consent NZ, SOP for sponsor consent oversight NZ, SOP for CRO consent support NZ, SOP for ethics committee consent approval NZ, SOP for Medsafe consent compliance, SOP for HDEC informed consent requirements, SOP for consent process auditing NZ, SOP for subject privacy in consent NZ, SOP for consent archiving NZ, SOP for inspection readiness consent NZ, SOP for consent translations NZ, SOP for consent amendments NZ, SOP for GCP compliance informed consent NZ, SOP for regulatory submission consent NZ, SOP for trial subject protection consent NZ”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Informed Consent Process and Documentation SOP

Purpose

The purpose of this SOP is to establish standardized procedures for obtaining, documenting, and archiving informed consent in clinical trials in New Zealand. It ensures compliance with Medsafe, Health and Disability Ethics Committees (HDEC), and ICH GCP requirements to protect participants’ autonomy and rights.

Scope

This SOP applies to all clinical trials in New Zealand requiring informed consent from participants or legally acceptable representatives. It includes written, oral, and electronic consent (eConsent) processes, witness requirements, cultural considerations, and record retention.

Responsibilities

• Principal Investigator (PI): Ensures participants are adequately informed and that consent is obtained prior to trial participation.
• Clinical Research Coordinator (CRC): Assists in presenting trial information and documenting the consent process.
• Sponsor: Provides approved ICF templates, oversees training, and ensures updates are implemented across all sites.
• Regulatory Affairs (RA): Submits ICFs to HDEC for approval and ensures changes are tracked.
• CRO: Supports sponsor in site-level monitoring of the consent process.
• Quality Assurance (QA): Conducts audits of informed consent documentation and ensures compliance.

Accountability

The PI is accountable for ensuring that informed consent is properly obtained and documented at the site level. The sponsor is accountable for ensuring ICF compliance across all participating sites.

Procedure

1. Preparation of Consent Documents

1. Prepare ICF and Patient Information Sheet (PIS) in plain language, ensuring cultural appropriateness.
2. Submit documents to HDEC for review and approval.
3. Maintain version control in Consent Document Log (Annexure-1).

2. Consent Process

1. Present trial information in a private, distraction-free environment.
2. Allow sufficient time for participant questions and deliberation.
3. Involve whānau (family) if requested by participant.
4. Document subject understanding before signing.

3. Special Considerations

1. For illiterate subjects, obtain witnessed consent with thumb impression.
2. For vulnerable populations, ensure additional protections and witness involvement.
3. For eConsent, ensure system compliance with privacy and electronic signature regulations.

4. Documentation

1. Retain signed ICFs in ISF and provide a copy to the participant.
2. Log all consent events in Consent Documentation Log (Annexure-2).

5. Archiving

1. Maintain consent records for a minimum of 10 years after trial completion.
2. Ensure records are readily available for audits and inspections.

Abbreviations

• ICF: Informed Consent Form
• PIS: Patient Information Sheet
• PI: Principal Investigator
• CRC: Clinical Research Coordinator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CRO: Contract Research Organization
• HDEC: Health and Disability Ethics Committees
• Medsafe: Medicines and Medical Devices Safety Authority
• ISF: Investigator Site File
• TMF: Trial Master File
• GCP: Good Clinical Practice

Documents

1. Consent Document Log (Annexure-1)
2. Consent Documentation Log (Annexure-2)
3. eConsent System Compliance Checklist (Annexure-3)

References

• HDEC — Health and Disability Ethics Committees
• Medsafe — Medicines and Medical Devices Safety Authority
• ICH E6(R2) Good Clinical Practice
• WHO Clinical Trial Standards

Version: 1.0

Approval

Annexures

Annexure-1: Consent Document Log

Annexure-2: Consent Documentation Log

Annexure-3: eConsent System Compliance Checklist

Revision History

For more SOPs visit: Pharma SOP.